Drawing for MAXYGENE INSIDE

USPTO serial 76098617

MAXYGENE INSIDE

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
Examiner
HICKEY,TONI
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MAXYGENE INSIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephanie K. Wade

STEPHANIE K WADE ARENT FOX KINTNER PLOTKIN ET AL1050 CONNECTICUT AVE NWWASHINGTON, DC 20036-5339UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001biochemicals, namely, polynucleic acids and polypeptides for scientific, research and commercial use; biochemicals for in vitro and in vivo scientific, research and commercial use; plant growth regulators; polypeptides, genes and polynucleic acids for agricultural use; and genes and enzymes used to produce chemicals for research and commercial applications pertaining to chemistry, biochemistry, biology, agriculture, pharmaceuticals, diagnostics, medicine, bioremediation, decontamination, detoxification, and cleaningACTIVE
005pharmaceutical preparations for the prevention and treatment of cardiovascular, dental and periodontal, dermatologic, endocrine and metabolic, gastrointestinal, genetic, hematologic, hepatic, immunologic, lymphatic, osteologic, neurologic, ophthalmic, psychiatric, respiratory tract, and renal and urinary tract diseases and disorders; pharmaceutical preparations, namely, analgesics, antibiotics, anti-cancer preparations, anti-infectives, anti-parasitic, antivirals; insulin; hormones; medical diagnostic preparations and reagents; herbicides, pesticides, biopesticides, miticides, and weed killers, all for agricultural and domestic use; vaccines; adjuvants for use with vaccinesACTIVE
031living plants, namely, transgenic plantsACTIVE
040directed evolution services, namely, the recombination of genes customized to the specification of others to produce novel gene sequences for use in science, research, chemistry, agriculture, medicine, and industryACTIVE
042chemical research services; scientific research services; research and testing services in the fields of bacteriology and virology; research and product development services for others in the fields of genetics and gene therapy, transgenic plants, chemistry, pharmaceuticals, medical diagnostics, pesticides, biopesticides, cytotoxic agents, bacteriology, virology, biocatalysis, metabolic pathways and biochemical pathwaysACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 28, 2002ABN1ABANDONMENT - EXPRESS MAILED
Mar 20, 2002ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 13, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 10, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 10, 2001ZZZYPREVIOUS ACTION COUNT WITHDRAWN
May 4, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 4, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 6, 2000DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance